{"id":"W4393301802","doi":"10.1016/s1470-2045(24)00100-1","title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Chemoradiotherapy; Placebo; Regimen; Head and neck squamous-cell carcinoma; Clinical endpoint; Internal medicine; Radiation therapy; Oncology; Head and neck cancer; Clinical trial; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001947499,0.002230705,0.004028751,0.0005307814,0.0005990712,0.001274587,0.001235754,0.002248081,0.008720992],"category_scores_gemma":[0.00164512,0.001004434,0.002853988,0.0005909005,0.001355741,0.001542743,0.0005160398,0.003701141,0.001546497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009926538,"about_ca_system_score_gemma":0.001232458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002198871,"about_ca_topic_score_gemma":0.003916849,"domain_scores_codex":[0.999365,0.0003051979,0.00003776705,0.0001429876,0.00004262578,0.0001063402],"domain_scores_gemma":[0.9993663,0.0001998745,0.0001330345,0.00005663541,0.00004205104,0.0002020077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9872683,0.002609881,0.0001611226,0.0006255006,0.0007658011,0.00002034756,0.0000388414,0.0002056849,0.001278114,0.00006972494,0.0003984719,0.006558238],"study_design_scores_gemma":[0.9719768,0.02653363,0.0005171087,0.00002595681,0.0003313301,0.00001186944,0.00001510382,0.0001395641,0.0001274227,0.00007477983,0.0002375995,0.000008706865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772938,0.009864717,0.000841198,0.0009889674,0.001419969,0.004962569,0.001396557,0.0001806578,0.003051569],"genre_scores_gemma":[0.9789749,0.00522485,0.001397617,0.001353115,0.0006271545,0.00505535,0.001107841,0.00003440748,0.006224725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008720992,"threshold_uncertainty_score":0.02917463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0493403772247069,"score_gpt":0.3628449011368754,"score_spread":0.3135045239121685,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}